Plasma angiotensin-converting enzyme 2 (ACE2) is a marker for renal outcome of diabetic kidney disease (DKD) (U-CARE study 3).
Ueno A, Onishi Y, Mise K, Yamaguchi S, Kanno A, Nojima I, Higuchi C, Uchida HA, Shikata K, Miyamoto S, Nakatsuka A, Eguchi J, Hida K, Katayama A, Watanabe M, Nakato T, Tone A, Teshigawara S, Matsuoka T, Kamei S, Murakami K, Shimizu I, Miyashita K, Ando S, Nunoue T, Wada J.
Ueno A, et al. Among authors: matsuoka t.
BMJ Open Diabetes Res Care. 2024 May 30;12(3):e004237. doi: 10.1136/bmjdrc-2024-004237.
BMJ Open Diabetes Res Care. 2024.
PMID: 38816205
Free PMC article.